All the participants are expected to be able to conduct in-space demonstrations by 2025 and show that their technology is capable of "new high-rate and high-capacity two-way communications." NASA will sign multiple long-term contracts with the companies that succeed in developing effective communication technologies for near-Earth operations by 2030.
Oramed Subsidiary Oravax Medical Signs Cooperation and Purchase Agreement for an Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccines with Tan Thanh Holdings to Commercialize in Southeast Asia
December 29, 2021
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its subsidiary, Oravax Medical, has signed
